Cohance Lifesciences Company Profile
What is the competitive landscape for COHANCE LIFESCIENCES
COHANCE LIFESCIENCES has four approved drugs.
Summary for Cohance Lifesciences
| US Patents: | 0 |
| Tradenames: | 4 |
| Ingredients: | 4 |
| NDAs: | 4 |
Drugs and US Patents for Cohance Lifesciences
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cohance Lifesciences | MALATHION | malathion | LOTION;TOPICAL | 091559-001 | May 23, 2012 | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Cohance Lifesciences | GLYCOPYRROLATE | glycopyrrolate | SOLUTION;ORAL | 212467-001 | Jul 5, 2022 | AA | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Cohance Lifesciences | CALCIUM ACETATE | calcium acetate | CAPSULE;ORAL | 211038-001 | Feb 21, 2020 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Cohance Lifesciences | CHLOROQUINE PHOSPHATE | chloroquine phosphate | TABLET;ORAL | 214756-001 | Sep 3, 2021 | AA | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
